• 본문 바로가기(Skip Contents)
ENGLISH
  • KOREAN
  • HOME

corestem

  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • SLE
    • CA
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

전체메뉴

전체메뉴

  • ABOUT US

    Overview History Manufacturing facility Our Company
  • PRODUCT

    ALS (NeuroNata-R®) Lou Gehrig's disease
  • PIPELINE

    Pipeline SLE CA
  • R&D

    Stem Cell Therapy
  • IR

    Stock Information Disclosures Finances Announcement of Settlement IR Inquiry
  • PR

    Press Report Notice Media Online Inquiry
  • HOME
ENGLISH
  • KOREAN
  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • Target Disease
    • Lupus
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

IR

Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

  • Stock Information
  • Disclosures
  • Finances
  • Announcement of Settlement
  • IR Inquiry
Announcement of Settlement
  • Stock Information
  • Disclosures
  • Finances
  • Announcement of Settlement
  • IR Inquiry